Experts quoted in the piece suggest the spread of GLP-1 drugs could shape how non-users feel about their own bodies and health.
Recap by typeshit. Post by Facebook on Facebook.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Healio
The doctor screens for thyroid cancer history, pancreatitis and gallbladder disease before starting incretin drugs, and checks in within four weeks of each dose step.
Avi Roy explains why only about 1% to 2% of the semaglutide tablet reaches the blood, while most of a starting Foundayo dose does.
Loading…